Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Aminolevulinic Acid Hydrochloride in Sarcoma: NCT07038278 Clinical Landscape Report 2026
15 October 2026
NCT07038278 clinical landscape for Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Human umbilical cord mesenchymal stem cells(Beike Biotechnology) in Systemic Lupus Erythematosus: NCT07041801 Clinical Landscape Report 2026
15 October 2026
NCT07041801 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Obinutuzumab β in Lupus Nephritis: NCT07044115 Clinical Landscape Report 2026
15 October 2026
NCT07044115 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AZD-8205 in Malignant Solid Neoplasm: NCT07044336 Clinical Landscape Report 2026
15 October 2026
NCT07044336 clinical landscape for Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sulforadex in Melanoma, Cutaneous Malignant: NCT07040280 Clinical Landscape Report 2026
15 October 2026
NCT07040280 clinical landscape for Melanoma, Cutaneous Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Multiple Myeloma: NCT07045909 Clinical Landscape Report 2026
15 October 2026
NCT07045909 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Myeloid Tumor: NCT07046078 Clinical Landscape Report 2026
15 October 2026
NCT07046078 clinical landscape for Myeloid Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07044687 Clinical Landscape Report 2026
15 October 2026
NCT07044687 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Myeloid Tumor: NCT07044544 Clinical Landscape Report 2026
15 October 2026
NCT07044544 clinical landscape for Myeloid Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Atezolizumab in Soft Tissue Sarcoma: NCT07049848 Clinical Landscape Report 2026
15 October 2026
NCT07049848 clinical landscape for Soft Tissue Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Romiplostim in Thrombocytopenia: NCT07048249 Clinical Landscape Report 2026
15 October 2026
NCT07048249 clinical landscape for Thrombocytopenia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LUCAR-G79 in Idiopathic Inflammatory Myopathies: NCT07049081 Clinical Landscape Report 2026
15 October 2026
NCT07049081 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…